Ambassador Advisors »

Halozyme Therapeutics shares owned by Ambassador Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Ambassador Advisors from 13F filings

Historical chart of Ambassador Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Ambassador Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Ambassador Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6M 23k 67.30

More positions owned by Ambassador Advisors

Northern Lts Fd Tr Iv Inspire Corp Bd (IBD)
Northern Lts Fd Tr Iv Inspire Growth E (GLRY)
Ishares Gold Tr Ishares New (IAU)
Palantir Technologies Cl A (PLTR)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Etf Opportunities Trust Idx Dynamic Fixe (DYFI)
Northern Lts Fd Tr Iv Inspire Intl Etf (WWJD)
Strategy Eventide High Di (ELCV)
Xometry Class A Com (XMTR)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Etf Opportunities Trust Idx Alternative (GLDB)
Shopify Cl A Sub Vtg Shs (SHOP)
Broadcom (AVGO)
Ishares Silver Tr Ishares (SLV)

View all positions for Ambassador Advisors

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics